pilocarpine has been researched along with valdecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bankstahl, M; Löscher, W; Polascheck, N | 1 |
1 review(s) available for pilocarpine and valdecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for pilocarpine and valdecoxib
| Article | Year |
|---|---|
The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
Topics: Analysis of Variance; Animals; Cell Count; Cell Death; Cerebral Cortex; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Electrodes, Implanted; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Epilepsy, Temporal Lobe; Female; Isoxazoles; Motor Activity; Neurons; Neuroprotective Agents; Pilocarpine; Random Allocation; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Video Recording | 2010 |